You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion’s Mother and Child Health campaign for Asia and MEA announced

Details were unveiled during our first televised Regional Distributor Meeting on July 14th-15th

read more 

CORPORATE

COVID-19. Kedrion partners with Columbia University Irving MC

Kedrion and Columbia University release video statements

read more 

EVENTS

ISTH, Kedrion supports symposium on the importance of inhibitor eradication

The central theme of the round table will be the optimization of the treatment of patients with Hemophilia A

read more 
  1. FEATURED STORIES - 04-01-2020

    In memory of Fabrizio Fabbrizzi

    Written by: Albert Farrugia

    read more 
  2. EVENTS - 25-11-2019

    Kedrion alongside IPOPI at the IPIC Congress in Madrid

    The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus

    read more 
  3. EVENTS - 15-11-2019

    Kedrion keeps Hemophilia therapy debate flowing in Latin America

    A recent CLAHT Congress symposium restates current and future role of replacement therapy

    read more 
  4. CORPORATE - 16-10-2019

    FSI SGR enters Kedrion share capital

    The company continues with its growth and development strategy

    read more 

Pages

For more information please contact: pressoffice@kedrion.com